Completed × Glioblastoma × Chemotherapy, Adjuvant × Clear all GW572016 to Treat Recurrent Malignant Brain Tumors
Phase 2 Completed
9 enrolled
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
24 enrolled
Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma
Phase 2 Completed
59 enrolled 8 charts
Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
Phase 2 Completed
43 enrolled 14 charts
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
45 enrolled
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 2 Completed
170 enrolled
Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas
Phase NA Completed
Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme
Phase 2 Completed
83 enrolled
Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1/2 Completed
20 enrolled
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
50 enrolled
Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma
Phase 1 Completed
18 enrolled
High Light and Low Light Dose PDT in Glioma
Phase 3 Completed
1 enrolled
Brachytherapy in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed